Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue
about
Natural selection of tumor variants in the generation of "tumor escape" phenotypesA paradigm shift: Cancer therapy with peptide-based B-cell epitopes and peptide immunotherapeutics targeting multiple solid tumor types: Emerging concepts and validation of combination immunotherapyAACR centennial series: the biology of cancer metastasis: historical perspectiveCombination treatment with HER-2 and VEGF peptide mimics induces potent anti-tumor and anti-angiogenic responses in vitro and in vivoNeoadjuvant chemoimmunotherapy in locally advanced breast cancer: a new avenue to be explored.VEGF expression, microvessel density and dendritic cell decrease in thyroid cancer.Numerical simulation of vascular tumour growth under antiangiogenic treatment: addressing the paradigm of single-agent bevacizumab therapy with the use of experimental data.Peptide vaccines and targeting HER and VEGF proteins may offer a potentially new paradigm in cancer immunotherapyLymphangiogenesis and cancerDendritic cell dysfunction in cancer: a mechanism for immunosuppression.Antitumor effects of vaccine consisting of dendritic cells pulsed with tumor RNA from gastric cancer.Dendritic cells and tumor microenvironment: a dangerous liaisonEffect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancerIntratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies?Clinicopathological and prognostic significance of galectin-1 and vascular endothelial growth factor expression in gastric cancerVascular endothelial growth factor and immunosuppression in cancer: current knowledge and potential for new therapy.Inflammatory cell infiltration of tumors: Jekyll or Hyde.The roles of mast cells in anticancer immunity.The influence of different culture microenvironments on the generation of dendritic cells from non-small-cell lung cancer patients.Immunological off-target effects of standard treatments in gastrointestinal cancersDisarming dendritic cells: a tumor strategy to escape from immune control?Dendritic cell vaccines for the immunocompromised patient: prevention of influenza virus infection.Lymphocyte subpopulation and dendritic cell phenotyping during antineoplastic therapy in human solid tumors.Cross-talk between tumor and myeloid cells: how to tip the balance in favor of antitumor immunity.Nanoengineered strategies to optimize dendritic cells for gastrointestinal tumor immunotherapy: from biology to translational medicine.Vascular endothelial growth factor partially inhibits the trastuzumab-mediated antibody-dependent cellular cytotoxicity of human monocytes.Prognostic significance of microvessel density and vascular endothelial growth factor (VEGF) expression in non-Hodgkin's lymphoma.Prognostic significance of RCAS1 expression in relation to the infiltration of dendritic cells and lymphocytes in patients with esophageal carcinoma.Role of dendritic cells in progression and clinical outcome of colon cancer.High expressions of galectin-1 and VEGF are associated with poor prognosis in gastric cancer patients.Expression of inducible nitric oxide synthase is significantly correlated with expression of vascular endothelial growth factor and dendritic cell infiltration in patients with advanced gastric carcinoma.Targeting VEGF receptors with non-neutralizing cyclopeptides for imaging applications.Tumor Immuno-Environment in Cancer Progression and Therapy.Differential Effects of Viscum album Preparations on the Maturation and Activation of Human Dendritic Cells and CD4⁺ T Cell Responses.Dendritic cells in precancerous lesions of the larynx.The expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinoma.Expression of vascular endothelial growth factor can predict distant metastasis and disease-free survival for clinical stage III rectal cancer following 30-Gy/10-f preoperative radiotherapy.Clinicopathological variables associated with lymph node metastasis in submucosal invasive gastric cancer.Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.Vascular endothelial growth factor inhibits the function of human mature dendritic cells mediated by VEGF receptor-2.
P2860
Q24551158-54BB88D4-B1B4-4169-B4E3-41C794FF3839Q26824462-B4D530F6-8F6E-4C7C-A533-76361D0B5590Q33683443-22104B4C-B5A1-4EBA-83E0-BD0FBDE42C9CQ34787422-8126F88D-691D-4368-9174-BB359E5D424FQ35095352-69802F29-ADE3-4735-A8CD-C474F94C3942Q35613202-30E4A2B7-B46A-49A8-80C6-CC7149219254Q35966871-99A5A4D0-D4D2-4E69-84CC-15D3A8D79AEDQ36116250-1499D59F-BFD8-4C10-9E46-A23AB5D71570Q36137692-0A32F7B2-D9AE-4AB5-AE40-E286C832FD76Q36262281-77C6193E-F920-4D12-BCA9-F6A901907FD7Q36474090-A344FED7-F1C0-4379-A88C-475D8C122964Q36569018-6F6416DE-5C0E-4427-9CDE-413F2715501BQ36597391-DD1AE22F-E277-48CD-BAA3-434D448020DDQ36617976-BBA684B4-02F3-4C47-9F89-B4B1B953ECB5Q36759226-737080BE-2DEC-47C9-92A7-57FC02F4BD3BQ36764907-92AED840-E72C-48C4-91E5-4A094B72E0F9Q36918692-1E18C778-95C4-4A78-BD89-DC9DD02CA903Q37256987-A3849B2D-D808-4246-9329-F1745BA9D9CDQ37397746-F591AD3D-B88B-4496-B1D9-0A5705B166EDQ37404086-9F2DCAE6-233E-4721-BED2-676FECE0B528Q37755322-28C5EDE6-5731-4E66-8D05-303314339A55Q37771941-4311F638-5D1D-41E9-A700-A0A4C68F9F06Q37821374-B543B115-26DE-45E6-8BFD-75F33BA098E8Q37822746-75F789C9-31EB-4261-A61E-935C74D89109Q38269126-2FDAE78E-E245-4992-A05F-737BEC82EB60Q40032309-81655FDF-9BB7-4955-AFB0-41EA05A7728DQ40532078-B7C4F359-59D1-43BF-B015-B06003D83097Q44028394-7E87B4DC-C77F-4861-BD35-01629A4CF6F1Q44233254-790F8A2E-0517-4F4B-ADDE-25228C538D97Q44957730-DC202A44-A222-46F3-96F7-B6DB4600EAE0Q46601903-176B6B53-C6F1-445B-8F3F-CDC851E88063Q49343443-A54E5CD9-6357-4E70-B34D-DFC64917B1F7Q49592937-7219F96E-8DE9-4847-81A7-0322032F967FQ51634430-91573D0D-4845-49C4-AA63-37564E0204E9Q52029646-F6DC8906-EB07-4F50-8C50-E35907051B30Q52141308-AECB7C47-3B9A-41F5-8DA9-26424D355345Q53269776-BE2AA3A6-C6D5-4A11-A499-037A1E960DF5Q53509724-DB2BB5EB-D068-49C1-A1D9-968BA71EDB42Q53574259-DFF94853-895D-4EEE-96D6-94E73D31EA68Q54572755-D7F9C91F-1EE8-4A25-969F-EC600FFAB8B9
P2860
Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Relationship between the expre ...... gastric adenocarcinoma tissue
@ast
Relationship between the expre ...... gastric adenocarcinoma tissue
@en
type
label
Relationship between the expre ...... gastric adenocarcinoma tissue
@ast
Relationship between the expre ...... gastric adenocarcinoma tissue
@en
prefLabel
Relationship between the expre ...... gastric adenocarcinoma tissue
@ast
Relationship between the expre ...... gastric adenocarcinoma tissue
@en
P2093
P2860
P356
P1476
Relationship between the expre ...... gastric adenocarcinoma tissue
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1998.725
P407
P577
1998-12-01T00:00:00Z